These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 26648535
1. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? Pawlyn C, Fowkes L, Otero S, Jones JR, Boyd KD, Davies FE, Morgan GJ, Collins DJ, Sharma B, Riddell A, Kaiser MF, Messiou C. Leukemia; 2016 Jun; 30(6):1446-8. PubMed ID: 26648535 [No Abstract] [Full Text] [Related]
3. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma. Lai AYT, Riddell A, Barwick T, Boyd K, Rockall A, Kaiser M, Koh DM, Saffar H, Yusuf S, Messiou C. Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214 [Abstract] [Full Text] [Related]
8. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response. Park HY, Kim KW, Yoon MA, Lee MH, Chae EJ, Lee JH, Chung HW, Yoon DH. Cancer Imaging; 2020 Jan 30; 20(1):14. PubMed ID: 32000858 [Abstract] [Full Text] [Related]
9. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study. Wu C, Huang J, Xu WB, Guan YJ, Ling HW, Mi JQ, Yan H. Acad Radiol; 2018 Jul 30; 25(7):904-914. PubMed ID: 29373210 [Abstract] [Full Text] [Related]
13. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma. Stecco A, Buemi F, Iannessi A, Carriero A, Gallamini A. Leuk Lymphoma; 2018 Nov 30; 59(11):2546-2556. PubMed ID: 29431555 [Abstract] [Full Text] [Related]
16. Whole body diffusion weighted MRI--a new view of myeloma. Messiou C, Kaiser M. Br J Haematol; 2015 Oct 30; 171(1):29-37. PubMed ID: 26013304 [Abstract] [Full Text] [Related]
17. Comparison of Whole-Body DWI and 18F-FDG PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma. Chen J, Li C, Tian Y, Xiao Q, Deng M, Hu H, Wen B, He Y. AJR Am J Roentgenol; 2019 Sep 30; 213(3):514-523. PubMed ID: 31166755 [Abstract] [Full Text] [Related]
18. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE. Eur Radiol; 2019 Aug 30; 29(8):4503-4513. PubMed ID: 30413957 [Abstract] [Full Text] [Related]
19. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma. Narquin S, Ingrand P, Azais I, Delwail V, Vialle R, Boucebci S, Tasu JP. Diagn Interv Imaging; 2013 Jun 30; 94(6):629-36. PubMed ID: 23683788 [Abstract] [Full Text] [Related]